MRI造影剤市場：製品、投与経路、用途、エンドユーザー別-2025～2030年の世界予測

MRI造影剤市場の2023年の市場規模は25億米ドルで、2024年には26億7,000万米ドルに達すると予測され、CAGR 7.54％で成長し、2030年には41億6,000万米ドルに達すると予測されています。

MRI造影剤は、磁気共鳴画像（MRI）スキャンの質を高め、病状のより正確な診断と評価を可能にするために使用される特殊な薬剤です。ガドリニウムを主成分とするこれらの薬剤は、水分子の磁気特性を変化させ、内部構造、組織、異常の可視性を向上させる。これらの薬剤の必要性は、特に腫瘍、炎症、血管疾患を検出するための診断手順における高解像度画像の必要性から生じています。用途としては、神経学、心臓病学、腫瘍学、筋骨格系イメージングに広く利用されています。最終用途は主に病院、画像診断センター、研究機関です。

MRI造影剤市場は、慢性疾患の増加、MRI技術の進歩、低侵襲診断手技に対する需要の高まりによって活況を呈しています。加えて、高齢化と医療支出の増加が市場成長の原動力となっています。腎障害やアレルギーのある患者に対応するため、非ガドリニウムベースの薬剤や排泄の容易さを約束する新規製剤の開発には機会があふれています。これらを活用するために、企業は安全性プロファイルの向上と適用範囲の拡大を目指した研究開発活動に投資すべきです。

しかし、厳しい規制要件、高額な画像処理費用、ガドリニウムの滞留に関する安全性の懸念などの課題も残っています。また、CTスキャンなどの代替画像モダリティや、AIを活用した画像分析などの新技術との競合も成長を妨げる可能性があります。さらに、一部の地域では先進的なMRI技術へのアクセスが制限されており、市場の拡大が制約されています。

技術革新については、生分解性造影剤や非金属造影剤の探求が有望な道筋を示します。また、副作用の低減や標的特異性の強化に焦点を当てた調査も成長を促進する可能性があります。規制状況が複雑であるため、市場関係者はコンプライアンスと市場での存在感を維持するために、進化するガイドラインに対応する必要があります。全体として、市場は成長する態勢にあるが、その可能性を十分に活用するためには、技術的、経済的、規制的課題の中で戦略的なナビゲーションが必要です。

市場力学：急速に進化するMRI造影剤市場の主要市場洞察を公開

MRI造影剤市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の有病率の上昇
  • 診断センターと病院数の増加
  • 造影剤の承認増加
• 市場抑制要因
  • MRI造影剤の高コスト
• 市場機会
  • 技術的に先進的なMRI造影剤の採用
  • 早期診断に対する意識の高まり
• 市場課題
  • 低開発国における先進治療へのアクセスの悪さ

ポーターのファイブフォース：MRI造影剤市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：MRI造影剤市場における外部からの影響の把握

外部マクロ環境要因は、MRI造影剤市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：MRI造影剤市場における競合情勢の把握

MRI造影剤市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：MRI造影剤市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、MRI造影剤市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：MRI造影剤市場における成功への道筋を描く

MRI造影剤市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の有病率の上昇
    • 診断センターと病院の増加
    • 造影剤の承認増加
  • 抑制要因
    • MRI造影剤のコストが高い
  • 機会
    • 技術的に進歩したMRI造影剤の採用
    • 早期診断に関する意識の向上
  • 課題
    • 発展途上国における先進的治療法へのアクセスの難しさ
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 MRI造影剤市場：製品別

• イントロダクション
• 常磁性造影剤
  • 血液プール造影剤
  • 細胞外液剤
  • 臓器特異的薬剤
• 超磁性造影剤

第7章 MRI造影剤市場：投与経路別

• イントロダクション
• 注射
• 経口

第8章 MRI造影剤市場：用途別

• イントロダクション
• 胃腸
• 肝胆道系
• 静脈内
• 神経画像診断

第9章 MRI造影剤市場：エンドユーザー別

• イントロダクション
• 外来手術センター
• 診断センター
• 病院

第10章 南北アメリカのMRI造影剤市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のMRI造影剤市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのMRI造影剤市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Acro Lifesciences（I）Pvt. Ltd.
• Bayer AG
• Beijing Beilu Pharmaceutical Co., Ltd.
• Bracco Imaging S.p.A
• Daiichi Sankyo Company, Limited
• General Electric Company
• Guerbet SA
• iMAX Diagnostic Imaging Limited
• Lantheus Medical Imaging, Inc.
• Miltenyi BIoTec B.V. & Co. KG
• Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd.
• SANOCHEMIA Pharmazeutika GmbH
• Spago Nanomedical AB
• Trivitron Healthcare
• Vitalquan, LLC

LIST OF FIGURES

• FIGURE 1. MRI CONTRAST MEDIA AGENTS MARKET RESEARCH PROCESS
• FIGURE 2. MRI CONTRAST MEDIA AGENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. MRI CONTRAST MEDIA AGENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. MRI CONTRAST MEDIA AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MRI CONTRAST MEDIA AGENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MRI CONTRAST MEDIA AGENTS MARKET DYNAMICS
• TABLE 7. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY BLOOD POOL CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY EXTRACELLULAR FLUID AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ORGAN-SPECIFIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY SUPERMAGNETIC CONTRAST AGENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY HEPATOBILIARY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY NEUROLOGICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 44. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 45. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 71. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 72. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 76. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 77. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 162. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 163. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 182. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 183. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 187. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 188. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. MRI CONTRAST MEDIA AGENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. MRI CONTRAST MEDIA AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

The MRI Contrast Media Agents Market was valued at USD 2.50 billion in 2023, expected to reach USD 2.67 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 4.16 billion by 2030.

MRI contrast media agents are specialized drugs used to enhance the quality of magnetic resonance imaging (MRI) scans, enabling more accurate diagnosis and assessment of medical conditions. These agents, primarily gadolinium-based, alter the magnetic properties of water molecules, improving the visibility of internal structures, tissues, and abnormalities. Their necessity stems from the need for high-resolution images in diagnostic procedures, particularly for detecting tumors, inflammation, and vascular disease. Application-wise, they are extensively utilized in neurology, cardiology, oncology, and musculoskeletal imaging. End-use primarily spans hospitals, diagnostic imaging centers, and research institutions.

The market for MRI contrast media agents is buoyed by increasing incidences of chronic diseases, advancements in MRI technology, and growing demand for minimally invasive diagnostic procedures. Additionally, the aging population and rising healthcare expenditure are driving market growth. Opportunities abound in the development of non-gadolinium-based agents and novel formulations that promise easier excretion, catering to patients with renal impairment or allergies. To capitalize on these, businesses should invest in R&D activities aimed at enhancing safety profiles and broadening application scopes.

However, challenges persist, such as stringent regulatory requirements, high costs of imaging procedures, and safety concerns related to gadolinium retention. Competition from alternative imaging modalities, like CT scans, and emerging technologies, such as AI-driven imaging analyses, could also hamper growth. Moreover, certain regions face limited access to advanced MRI technology, constraining market expansion.

For innovation, exploration into biodegradable and non-metallic contrast agents presents a promising avenue. Research focusing on reducing adverse reactions and enhancing target specificity could also spur growth. The intricate regulatory landscape necessitates that market players stay aligned with evolving guidelines to maintain compliance and market presence. Overall, the market is poised for growth but requires strategic navigation amidst technological, economic, and regulatory challenges to fully harness its potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving MRI Contrast Media Agents Market

The MRI Contrast Media Agents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of chronic disorders
  • Growing number of diagnostic centers and hospitals
  • Increasing approvals of contrast agents
• Market Restraints
  • High cost of MRI contrast media agents
• Market Opportunities
  • Introduction of technologically advanced MRI contrast agents
  • Increasing awareness regarding early diagnosis
• Market Challenges
  • Inaccessibility of advanced therapeutics in underdeveloped countries

Porter's Five Forces: A Strategic Tool for Navigating the MRI Contrast Media Agents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the MRI Contrast Media Agents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the MRI Contrast Media Agents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the MRI Contrast Media Agents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the MRI Contrast Media Agents Market

A detailed market share analysis in the MRI Contrast Media Agents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the MRI Contrast Media Agents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the MRI Contrast Media Agents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the MRI Contrast Media Agents Market

A strategic analysis of the MRI Contrast Media Agents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the MRI Contrast Media Agents Market, highlighting leading vendors and their innovative profiles. These include Acro Lifesciences (I) Pvt. Ltd., Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Imaging S.p.A, Daiichi Sankyo Company, Limited, General Electric Company, Guerbet SA, iMAX Diagnostic Imaging Limited, Lantheus Medical Imaging, Inc., Miltenyi Biotec B.V. & Co. KG, Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd., SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, and Vitalquan, LLC.

Market Segmentation & Coverage

This research report categorizes the MRI Contrast Media Agents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Paramagnetic Contrast Agents and Supermagnetic Contrast Agent. The Paramagnetic Contrast Agents is further studied across Blood Pool Contrast Agents, Extracellular Fluid Agents, and Organ-Specific Agents.
• Based on Route of Administration, market is studied across Injection and Oral.
• Based on Application, market is studied across Gastrointestinal, Hepatobiliary, Intravenous, and Neurological Imaging.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic disorders
    • 5.1.1.2. Growing number of diagnostic centers and hospitals
    • 5.1.1.3. Increasing approvals of contrast agents
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of MRI contrast media agents
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of technologically advanced MRI contrast agents
    • 5.1.3.2. Increasing awareness regarding early diagnosis
  • 5.1.4. Challenges
    • 5.1.4.1. Inaccessibility of advanced therapeutics in underdeveloped countries
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. MRI Contrast Media Agents Market, by Product

• 6.1. Introduction
• 6.2. Paramagnetic Contrast Agents
  • 6.2.1. Blood Pool Contrast Agents
  • 6.2.2. Extracellular Fluid Agents
  • 6.2.3. Organ-Specific Agents
• 6.3. Supermagnetic Contrast Agent

7. MRI Contrast Media Agents Market, by Route of Administration

• 7.1. Introduction
• 7.2. Injection
• 7.3. Oral

8. MRI Contrast Media Agents Market, by Application

• 8.1. Introduction
• 8.2. Gastrointestinal
• 8.3. Hepatobiliary
• 8.4. Intravenous
• 8.5. Neurological Imaging

9. MRI Contrast Media Agents Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Diagnostic Centers
• 9.4. Hospitals

10. Americas MRI Contrast Media Agents Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific MRI Contrast Media Agents Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa MRI Contrast Media Agents Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Acro Lifesciences (I) Pvt. Ltd.
• 2. Bayer AG
• 3. Beijing Beilu Pharmaceutical Co., Ltd.
• 4. Bracco Imaging S.p.A
• 5. Daiichi Sankyo Company, Limited
• 6. General Electric Company
• 7. Guerbet SA
• 8. iMAX Diagnostic Imaging Limited
• 9. Lantheus Medical Imaging, Inc.
• 10. Miltenyi Biotec B.V. & Co. KG
• 11. Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd.
• 12. SANOCHEMIA Pharmazeutika GmbH
• 13. Spago Nanomedical AB
• 14. Trivitron Healthcare
• 15. Vitalquan, LLC